Multiple Choice
A patient who has received chemotherapy has a steadily decreasing white blood cell count. The chemotherapy will end on Tuesday afternoon. The oncologist has mentioned that a colony-stimulating factor will be started soon. The nurse knows that the appropriate time to start this medication is when?
A) While the patient is still receiving chemotherapy
B) Two hours after the chemotherapy ends
C) Wednesday afternoon, 24 hours after the chemotherapy ends
D) In 2 to 4 days, after the white blood cells have reached their nadir
Correct Answer:

Verified
Correct Answer:
Verified
Q2: During a patient's therapy with interleukins, the
Q3: A patient is to receive filgrastim (Neupogen)
Q4: Abatacept (Orencia) is prescribed for a patient
Q5: Aldesleukin [IL-2] (Proleukin) is prescribed for a
Q6: A patient who has received chemotherapy has
Q8: A patient has an order for the
Q9: The nurse is administering an interferon and
Q10: A patient will be receiving aldesleukin [IL-2]
Q11: A patient asks about his cancer treatment
Q12: During therapy with hematopoietic drugs, the nurse